"{\"id\":\"f9cd9f4e2aa54721a90214e74128046d\",\"object\":\"chat.completion\",\"model\":\"mistral-small-latest\",\"usage\":{\"prompt_tokens\":1082,\"completion_tokens\":1041,\"total_tokens\":2123},\"created\":1749696587,\"choices\":[{\"index\":0,\"message\":{\"content\":\"Here is the extracted information from the document, formatted as JSON for easy reference and future use:\\n\\n```json\\n{\\n  \\\"form_name\\\": \\\"Antimigraine Agents, Vyepti (Eptinezumab-jmmr) Prior Authorization (PA) Form\\\",\\n  \\\"provider\\\": \\\"HealthKeepers, Inc. | Anthem HealthKeepers Plus Medicaid products\\\",\\n  \\\"instructions\\\": \\\"If the following information is not complete, correct, or legible, the PA process can be delayed. Please use one form per member.\\\",\\n  \\\"sections\\\": {\\n    \\\"member_information\\\": {\\n      \\\"last_name\\\": \\\"Last name:\\\",\\n      \\\"first_name\\\": \\\"First name:\\\",\\n      \\\"medicaid_id_number\\\": \\\"Medicaid ID number:\\\",\\n      \\\"date_of_birth\\\": \\\"Date of birth:\\\",\\n      \\\"weight_in_kilograms\\\": \\\"Weight in kilograms:\\\"\\n    },\\n    \\\"prescriber_information\\\": {\\n      \\\"last_name\\\": \\\"Last name:\\\",\\n      \\\"first_name\\\": \\\"First name:\\\",\\n      \\\"npi_number\\\": \\\"NPI number:\\\",\\n      \\\"phone_number\\\": \\\"Phone number:\\\",\\n      \\\"fax_number\\\": \\\"Fax number:\\\"\\n    },\\n    \\\"drug_information\\\": {\\n      \\\"drug_name\\\": \\\"Drug name:\\\",\\n      \\\"drug_strength\\\": \\\"Drug strength:\\\",\\n      \\\"length_of_therapy\\\": \\\"Length of therapy:\\\",\\n      \\\"drug_form\\\": \\\"Drug form:\\\",\\n      \\\"dosing_frequency\\\": \\\"Dosing frequency:\\\",\\n      \\\"quantity\\\": \\\"Quantity:\\\"\\n    },\\n    \\\"drug_information_continued\\\": {\\n      \\\"member_last_name\\\": \\\"Member's last name:\\\",\\n      \\\"member_first_name\\\": \\\"Member's first name:\\\",\\n      \\\"preventive_treatment\\\": {\\n        \\\"preferred_agents\\\": [\\n          \\\"Aimovig\u00ae\\\",\\n          \\\"Ajovy\u00ae and Ajovy\u00ae autoinjector\\\",\\n          \\\"Emgality\u00ae pen and syringe (120 mg)\\\",\\n          \\\"Nurtec\u00ae ODT\\\"\\n        ],\\n        \\\"non_preferred_agents\\\": [\\n          \\\"Emgality\u00ae syringe (100 mg)\\\",\\n          \\\"Qulipta\u2122\\\",\\n          \\\"Vyepti\u00ae\\\"\\n        ]\\n      },\\n      \\\"acute_treatment\\\": {\\n        \\\"preferred_agents\\\": [\\n          \\\"Nurtec\u00ae ODT\\\",\\n          \\\"Ubrelvy\u2122\\\"\\n        ],\\n        \\\"non_preferred_agents\\\": [\\n          \\\"Reyvow\u00ae\\\",\\n          \\\"Trudhesa\u2122\\\",\\n          \\\"Zavzpret\u2122\\\"\\n        ]\\n      },\\n      \\\"preferred_agents_cannot_be_used\\\": \\\"Identify why the preferred agents cannot be used:\\\"\\n    },\\n    \\\"drug_information_questions\\\": {\\n      \\\"question_1\\\": {\\n        \\\"text\\\": \\\"Does the member have a diagnosis of migraine with or without aura based on International Classification of Headache Disorders (ICHD-III) diagnostic criteria?\\\",\\n        \\\"options\\\": [\\\"Yes\\\", \\\"No\\\"]\\n      },\\n      \\\"question_2\\\": {\\n        \\\"text\\\": \\\"Is the member \u2265 18 years of age?\\\",\\n        \\\"options\\\": [\\\"Yes\\\", \\\"No\\\"]\\n      },\\n      \\\"question_3\\\": {\\n        \\\"text\\\": \\\"Has the member been utilizing prophylactic intervention modalities (for example, pharmacotherapy, behavioral therapy, physical therapy, etc.)?\\\",\\n        \\\"options\\\": [\\\"Yes\\\", \\\"No\\\"]\\n      },\\n      \\\"question_4\\\": {\\n        \\\"text\\\": \\\"Does the member have a diagnosis of chronic migraines defined as 15 or more headache (tension-type-like and/or migraine-like) days per month for > three months?\\\",\\n        \\\"sub_questions\\\": [\\n          {\\n            \\\"text\\\": \\\"Member has had at least five attacks with features consistent with migraine (with and/or without aura);\\\",\\n            \\\"options\\\": [\\\"Yes\\\", \\\"No\\\"]\\n          },\\n          {\\n            \\\"text\\\": \\\"On at least eight days per month for > three months:\\\",\\n            \\\"sub_questions\\\": [\\n              {\\n                \\\"text\\\": \\\"Headaches have characteristics and symptoms consistent with migraine;\\\",\\n                \\\"options\\\": [\\\"Yes\\\", \\\"No\\\"]\\n              },\\n              {\\n                \\\"text\\\": \\\"Member suspected migraines are relieved by a triptan or ergot derivative medication;\\\",\\n                \\\"options\\\": [\\\"Yes\\\", \\\"No\\\"]\\n              }\\n            ]\\n          },\\n          {\\n            \\\"text\\\": \\\"Member has failed at least an eight-week trial of any two oral medications for the prevention of migraines (for example, antidepressants, beta blockers, antiepileptics) prior to initiation of eptinezumab;\\\",\\n            \\\"options\\\": [\\\"Yes\\\", \\\"No\\\"]\\n          },\\n          {\\n            \\\"text\\\": \\\"Member had an inadequate response (or unable to tolerate) a minimum trial of at least two preferred self-injectable CGRP options;\\\",\\n            \\\"options\\\": [\\\"Yes\\\", \\\"No\\\"]\\n          }\\n        ]\\n      }\\n    }\\n  }\\n}\\n```\\n\\nThis JSON structure can be used to extract and reference the information from a larger document in the future.\",\"tool_calls\":null,\"prefix\":false,\"role\":\"assistant\"},\"finish_reason\":\"stop\"}]}"